BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 20541059)

  • 1. ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma.
    Ng A; Constine LS; Advani R; Das P; Flowers C; Friedberg J; Hodgson DC; Schwartz CL; Wilder RB; Wilson LD; Yunes MJ
    Curr Probl Cancer; 2010; 34(3):211-27. PubMed ID: 20541059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria.
    Deming RL; Constine LS; Elman AJ; Hoppe RT; Mauch PM; Dosoretz DE; Pistenmaa DA; Prosnitz LR; Wolkov HB; Yahalom J; Chauvenet A; Connors JM; Glick JH; Leibel S
    Radiology; 2000 Jun; 215 Suppl():1269-79. PubMed ID: 11037546
    [No Abstract]   [Full Text] [Related]  

  • 3. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
    Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based study of follow-up care for Hodgkin lymphoma survivors: opportunities to improve surveillance for relapse and late effects.
    Hodgson DC; Grunfeld E; Gunraj N; Del Giudice L
    Cancer; 2010 Jul; 116(14):3417-25. PubMed ID: 20564062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of screening procedures for detecting recurrence of disease after complete response in patients with small cell lung carcinoma.
    Perez EA; Loprinzi CL; Sloan JA; Owens DT; Novotny PJ; Bonner JA
    Cancer; 1997 Aug; 80(4):676-80. PubMed ID: 9264350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACR appropriateness criteria follow-up of Hodgkin lymphoma.
    Ha CS; Hodgson DC; Advani R; Dabaja BS; Dhakal S; Flowers CR; Hoppe BS; Mendenhall NP; Metzger ML; Plastaras JP; Roberts KB; Shapiro R; Smith S; Terezakis SA; Winkfield KM; Younes A; Constine LS
    J Am Coll Radiol; 2014 Nov; 11(11):1026-1033.e3. PubMed ID: 25278496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
    Glanzmann C; Veraguth A; Lütolf UM
    Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
    Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
    Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive health care, 1999 update: 3. Follow-up after breast cancer. Canadian Task Force on Preventive Health Care.
    Temple LK; Wang EE; McLeod RS
    CMAJ; 1999 Oct; 161(8):1001-8. PubMed ID: 10551200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
    Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography.
    Sone S; Nakayama T; Honda T; Tsushima K; Li F; Haniuda M; Takahashi Y; Suzuki T; Yamanda T; Kondo R; Hanaoka T; Takayama F; Kubo K; Fushimi H
    Lung Cancer; 2007 Dec; 58(3):329-41. PubMed ID: 17675180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.
    Donaldson SS; Hancock SL; Hoppe RT
    Cancer J Sci Am; 1999; 5(6):325-33. PubMed ID: 10606471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of treatment for Hodgkin's disease: the University Hospital Sofia experience.
    Gocheva L; Koleva I
    Klin Onkol; 2010; 23(1):34-42. PubMed ID: 20192072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACR Appropriateness Criteria on Hodgkin's lymphoma: favorable prognosis stage I and II.
    Das P; Ng A; Constine LS; Hodgson DC; Mendenhall NP; Morris DE; Yunes MJ; Chauvenet AR; Hudson MM; Winter JN
    J Am Coll Radiol; 2008 Oct; 5(10):1054-66. PubMed ID: 18812149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
    Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
    Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.